TNFSF10 and neoplasm: Thus, while the serum cytokine signature of increased TNF-α and TRAIL expression observed are indicative of effector cell indirect anti-tumor responses following rLAS-uPA treatment, increased systemic circulating concentrations of these cytokines may also be causes of or contributors to the AE that were observed in the trial.